{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:51:44Z","timestamp":1758127904462,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.fertnstert.2020.02.111","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T06:05:27Z","timestamp":1590818727000},"page":"1205-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cycle day 2 insulin-like growth factor-1 serum levels as a prognostic tool to predict controlled ovarian hyperstimulation outcomes in poor responders"],"prefix":"10.1016","volume":"113","author":[{"given":"Limor","family":"Man","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Lekovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Canon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Rosenwaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0975-2554","authenticated-orcid":false,"given":"Daylon","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.02.111_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0015-0282(16)59170-5","article-title":"Outcome of in\u00a0vitro fertilization in women with low response to ovarian stimulation","volume":"47","author":"Pellicer","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humrep\/13.3.561","article-title":"Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH)","volume":"13","author":"de Ziegler","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib4","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.02.028","article-title":"Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial","volume":"97","author":"C\u00e9drin-Durnerin","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rbmo.2015.04.001","article-title":"To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!","volume":"31","author":"Griesinger","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib7","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/det306","article-title":"Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis","volume":"28","author":"Reynolds","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib9","first-page":"2250","article-title":"Both oral and transdermal estrogen increase growth hormone release in postmenopausal women\u2014a clinical research center study","volume":"81","author":"Friend","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11102-012-0426-4","article-title":"Estrogen treatment for acromegaly","volume":"15","author":"Shimon","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/oxfordjournals.humrep.a137514","article-title":"Insulin-like growth factors: the ovarian connection","volume":"6","author":"Adashi","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00063030-199911010-00006","article-title":"Somatomedin-1 (recombinant insulin-like growth factor-1): clinical pharmacology and potential treatment of endocrine and metabolic disorders","volume":"11","author":"Laron","year":"1999","journal-title":"BioDrugs"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib14","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/mend-5-12-1799","article-title":"Insulin-like growth factor receptor gene expression in the rat ovary: divergent regulation of distinct receptor species","volume":"5","author":"Hernandez","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/endo-125-1-572","article-title":"Rat ovarian insulin-like growth factor I (IGF-I) gene expression is granulosa cell-selective: 5'-untranslated mRNA variant representation and hormonal regulation","volume":"125","author":"Hernandez","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/molehr\/6.2.137","article-title":"Expression of receptors for insulin-like growth factor-I and transforming growth factor-beta in human follicles","volume":"6","author":"Qu","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib17","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/endo-129-6-3281","article-title":"Cellular pattern of insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the developing and mature ovarian follicle","volume":"129","author":"Zhou","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib18","first-page":"1526","article-title":"Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient","volume":"80","author":"Laron","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137403","article-title":"Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?","volume":"6","author":"Menashe","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/03014469100001452","article-title":"The comparative growth of Efe pygmies and African farmers from birth to age 5 years","volume":"18","author":"Bailey","year":"1991","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib21","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1210\/jcem.80.12.8530626","article-title":"Insulin-like growth factor I resistance in immortalized T cell lines from African Efe Pygmies","volume":"80","author":"Geffner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle-stimulating hormone levels on cycle day 3 are predictive of in\u00a0vitro fertilization outcome","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0015-0282(97)81369-6","article-title":"Relationships between insulin-like growth hormone factor-I and estradiol in reproductive aging","volume":"67","author":"Blake","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2265.1996.670491.x","article-title":"Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age","volume":"44","author":"Klein","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2001-18039","article-title":"Superovulation strategies for assisted reproductive technologies","volume":"19","author":"Davis","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.fertnstert.2012.11.044","article-title":"Consecutive gonadotropin-releasing hormone-antagonist in\u00a0vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?","volume":"99","author":"Reichman","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.fertnstert.2013.12.032","article-title":"Female age-related fertility decline. Committee Opinion No. 589","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0974-1208.117171","article-title":"Follicular fluid insulin like growth factor-1 (FF IGF-1) is a biochemical marker of embryo quality and implantation rates in in\u00a0vitro fertilization cycles","volume":"6","author":"Mehta","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib29","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1210\/jc.2014-1139","article-title":"IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human Cumulus granulosa cells","volume":"99","author":"Baumgarten","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/dex002","article-title":"Genome-wide interactions between FSH and insulin-like growth factors in the regulation of human granulosa cell differentiation","volume":"32","author":"Stocco","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib31","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1371\/journal.pone.0000340","article-title":"Role of ubiquitination in IGF-1 receptor signaling and degradation","volume":"2","author":"Sehat","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10815-008-9203-8","article-title":"Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients","volume":"25","author":"Duvan","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humrep\/det426","article-title":"Poor ovarian responders: to meta-analyse or not, that is the question","volume":"29","author":"Polyzos","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","article-title":"How to improve the probability of pregnancy in poor responders undergoing in\u00a0vitro fertilization: a systematic review and meta-analysis","volume":"91","author":"Kyrou","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09513590.2014.959919","article-title":"Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?","volume":"31","author":"Haas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/humupd\/dmp026","article-title":"Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis","volume":"15","author":"Kolibianakis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib37","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/en.2002-220087","article-title":"Growth hormone is required for ovarian follicular growth","volume":"143","author":"Bachelot","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/rep.1.00946","article-title":"Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice","volume":"131","author":"Slot","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib39","first-page":"152","article-title":"Genetic pituitary dwarfism with high serum concentation of growth hormone\u2014a new inborn error of metabolism?","volume":"2","author":"Laron","year":"1966","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib40","first-page":"903","article-title":"Effects of an Igf1 gene null mutation on mouse reproduction","volume":"10","author":"Baker","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.fertnstert.2005.04.031","article-title":"Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in\u00a0vitro fertilization in poor responders","volume":"84","author":"Dragisic","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9343(80)90470-2","article-title":"Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status","volume":"69","author":"Clemmons","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2014gonadotropin treatment","volume":"20","author":"Pe\u00f1arrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.02.111_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(00)00176-1","article-title":"Effects of\u00a0two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH)","volume":"62","author":"Balogh","year":"2000","journal-title":"Contraception"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220302417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220302417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:26:56Z","timestamp":1758011216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220302417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0015028220302417"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.02.111","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cycle day 2 insulin-like growth factor-1 serum levels as a prognostic tool to predict controlled ovarian hyperstimulation outcomes in poor responders","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.02.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}